1. Interleukin-6 and Tumor Growth Factor-β are Risk Factors for Idiopathic Epistaxis
- Author
-
Mohammad-Taghi Rezayati, Mahmood Sheikh Fathollahi, Ali Golshiri-Isfahani, Derek Kennedy, Gholamreza Asadikaram, Reza Bahramabadi, Mohammad Kazemi Arababadi, Mohammadreza Afrooz, and Soheila Rahmanzadeh-Shahi
- Subjects
0301 basic medicine ,medicine.hormone ,Adult ,Male ,medicine.medical_specialty ,medicine.medical_treatment ,Clinical Biochemistry ,Immunoglobulin E ,Gastroenterology ,Endothelins ,03 medical and health sciences ,0302 clinical medicine ,Risk Factors ,Internal medicine ,medicine ,Hypersensitivity ,Humans ,Interleukin 8 ,Risk factor ,Interleukin 6 ,biology ,business.industry ,Interleukin-6 ,Biochemistry (medical) ,Interleukin ,030104 developmental biology ,Cytokine ,Cross-Sectional Studies ,Epistaxis ,biology.protein ,Cytokines ,Female ,business ,Endothelin receptor ,030215 immunology - Abstract
Objective: To evaluate the serum levels of interleukin (IL)-6, IL-8, tumor necrosis factor (TNF)-alpha, tumor growth factor (TGF)-beta, endothelin, and immunoglobulin (Ig)E in patients with idiopathic epistaxis, compared with healthy control individuals. Methods: Serum levels of IL-6, IL-8, TNF-alpha, TGF-beta, endothelin, and IgE were evaluated in 110 patients with idiopathic epistaxis and 100 healthy controls using the enzyme-linked immunosorbent assay (ELISA) technique. Results: Serum levels of IL-6 (P
- Published
- 2018